Ameritas Investment Partners’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.66K | Hold |
2,570
| – | – | ﹤0.01% | 3018 |
|
|
2025
Q1 | $9.92K | Hold |
2,570
| – | – | ﹤0.01% | 2827 |
|
|
2024
Q4 | $15.9K | Hold |
2,570
| – | – | ﹤0.01% | 2729 |
|
|
2024
Q3 | $13.8K | Hold |
2,570
| – | – | ﹤0.01% | 2820 |
|
|
2024
Q2 | $8.61K | Hold |
2,570
| – | – | ﹤0.01% | 2968 |
|
|
2024
Q1 | $10.4K | Hold |
2,570
| – | – | ﹤0.01% | 2805 |
|
|
2023
Q4 | $6.81K | Hold |
2,570
| – | – | ﹤0.01% | 2927 |
|
|
2023
Q3 | $6.07K | Hold |
2,570
| – | – | ﹤0.01% | 2957 |
|
|
2023
Q2 | $16.2K | Hold |
2,570
| – | – | ﹤0.01% | 2670 |
|
|
2023
Q1 | $14.8K | Hold |
2,570
| – | – | ﹤0.01% | 2568 |
|
|
2022
Q4 | $22K | Hold |
2,570
| – | – | ﹤0.01% | 2523 |
|
|
2022
Q3 | $42K | Buy |
2,570
+515
| +25% | +$8.42K | ﹤0.01% | 2108 |
|
|
2022
Q2 | $28K | Hold |
2,055
| – | – | ﹤0.01% | 2358 |
|
|
2022
Q1 | $33K | Hold |
2,055
| – | – | ﹤0.01% | 2293 |
|
|
2021
Q4 | $44K | Buy |
2,055
+998
| +94% | +$21.4K | ﹤0.01% | 2199 |
|
|
2021
Q3 | $16K | Hold |
1,057
| – | – | ﹤0.01% | 2799 |
|
|
2021
Q2 | $21K | Buy |
+1,057
| New | +$21K | ﹤0.01% | 2703 |
|